Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Journal of Pathology

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64120-XPMID 11337362PMCID PMC1891957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Analysis by High Density cDNA Arrays of Altered Gene Expression in Human Intestinal Epithelial Cells in Response to Infection with the Invasive Enteric BacteriaSalmonella *

  2000cited by this paper
• Cathepsin H expression distinguishes oncocytomas from renal cell carcinomas.

  2000cited by this paper
• Decreased galectin‐3 expression in prostate cancer

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Molecular classification of cutaneous malignant melanoma by gene expression profiling

  2000cited by this paper
• Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma.

  2000cited by this paper
• Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress.

  2000cited by this paper
• Concentrations of galectin-3 in the sera of normal controls and cancer patients.

  2000cited by this paper
• Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations.

  2000cited by this paper
• Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma

  2000cited by this paper
• Novel investigative approaches for advanced renal cell carcinoma.

  2000cited by this paper
• Histopathology and molecular genetics of renal tumors toward unification of a classification system.

  1999cited by this paper
• Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.

  1999cited by this paper
• Exploring expression data: identification and analysis of coexpressed genes.

  1999influential reference
• Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.

  1999cited by this paper
• Serial microanalysis of renal transcriptomes.

  1999cited by this paper
• Renal oncocytosis: a morphologic study of fourteen cases.

  1999cited by this paper
• DNA arrays for analysis of gene expression.

  1999cited by this paper
• Renal tumors exhibiting granular cytoplasm.

  1999cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

  1999influential reference
• Renal tumors exhibiting granular cytoplasm.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Commentary Pattern Recognition and Arrays The Times Are A-Changing

  1999cited by this paper
• Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade.

  1998cited by this paper
• AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.

  1998cited by this paper
• Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly.

  1998cited by this paper
• Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

  1998cited by this paper
• Renal oncocytoma with t(5;12;11), der(1)t(1;8) and add(19): “true” oncocytoma or chromophobe adenoma?

  1997cited by this paper
• Sarcomatoid renal cell carcinoma: the chromophobe connection.

  1997cited by this paper
• Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

  1997cited by this paper
• Involvement of multiple loci on chromosome 3 in renal cell cancer development

  1997cited by this paper
• Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas.

  1997cited by this paper
• Erratum to ‘MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host’ [Cancer Lett. 109 (1996), 15–21]

  1997cited by this paper
• Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1.

  1996cited by this paper
• MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.

  1996cited by this paper
• MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host.

  1996cited by this paper
• Aggressive variants of chromophobe renal cell carcinoma

  1996cited by this paper
• Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma.

  1996cited by this paper
• The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma.

  1996cited by this paper
• Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.

  1995cited by this paper
• Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.

  1995cited by this paper
• Mutations of the VHL tumour suppressor gene in renal carcinoma

  1994cited by this paper
• Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues

  1994cited by this paper
• Low chromosome number in chromophobe renal cell carcinomas

  1992cited by this paper
• Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors

  1992cited by this paper
• The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney

  1992cited by this paper
• Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas

  1992cited by this paper
• Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas.

  1992cited by this paper
• Calbindin-D9k and parvalbumin are exclusively located along basolateral membranes in rat distal nephron.

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• Chromophobe cell renal carcinoma and its variants—a report on 32 cases

  1988cited by this paper
• The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct

  1988cited by this paper
• Renal tubular antigens in kidney tumors

  1972cited by this paper
• Cáncer

  1939cited by this paper

• MHC Class II and Beyond: Complex Role of CD74 in Cancer

  2026cites this paper
• Highlights of the First 100 Years of Publications on Kidney Disease in The American Journal of Pathology.

  2025cites this paper
• Disclosing the development and focus of sequencing and omics studies in kidney neoplasm research

  2025cites this paper
• TreeEM: Tree-enhanced ensemble model combining with feature selection for cancer subtype classification and survival prediction

  2025cites this paper
• CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells

  2024cites this paper
• The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma

  2024cites this paper
• Oral Cavity Beta-Defensin Levels Are Regulated Differently during Radiotherapy in Head and Neck Cancer Patients

  2023cites this paper
• The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells

  2023cites this paper
• Analysis of CD74 Occurrence in Oncogenic Fusion Proteins

  2023cites this paper
• The Diatom Cylindrotheca closterium and the Chlorophyll Breakdown Product Pheophorbide a for Photodynamic Therapy Applications

  2023cites this paper
• Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer

  2022cites this paper
• The diagnostic value of immunohistochemistry in the typing of renal tumors with eosinophylic cytoplasma.

  2020cites this paper
• An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC).

  2020cites this paper
• Defensins: A Double-Edged Sword in Host Immunity

  2020cites this paper
• Human Beta Defensins and Cancer: Contradictions and Common Ground

  2019cites this paper
• Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines

  2019cites this paper
• Major Subtypes of Renal Cell Carcinoma

  2019cites this paper
• Vimentin Overexpressions Induced by Cell Hypoxia Promote Vasculogenic Mimicry by Renal Cell Carcinoma Cells

  2019cites this paper
• MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential

  2019cites this paper
• Renal Mass Biopsy

  2018cites this paper
• Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas.

  2018cites this paper
• Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study.

  2018cites this paper
• Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

  2018cites this paper
• TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells

  2018cites this paper
• Management of Small Renal Masses

  2018influential citation
• Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma

  2018cites this paper
• High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti‐CD74‐drug conjugate

  2018cites this paper
• The prognostic significance of nuclear expression of PHF2 and C/EBPα in clear cell renal cell carcinoma with consideration of adipogenic metabolic evolution

  2017cites this paper
• DERVED FROM SURVIVIN

  2017cites this paper
• Expression of CD74 in Invasive Breast Carcinoma: Its Relation to Nottingham Prognostic Index, Hormone Receptors, and HER2 Immunoprofile

  2017cites this paper
• MIF- and CD74-Dependent Mechanisms

  2017cites this paper
• This information is current as Dextran Sodium Sulfate-Induced Colitis Expression and Reduce the Severity of Intestinal Epithelial Proinflammatory Gene Analogs Attenuate Induction of 4 Lipoxin A

  2017cites this paper
• University of Southern Denmark Identification and validation of novel prognostic markers in renal cell carcinoma

  2017cites this paper
• The multifaceted roles of the invariant chain CD74--More than just a chaperone.

  2016cites this paper
• Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015)

  2016cites this paper
• Gr upSM An Overview of Omics Technologies for Renal Cell Carcinoma Diagnosis and Profiling

  2016cites this paper
• Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma

  2016cites this paper
• Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levels

  2016cites this paper
• Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers

  2016cites this paper
• The Role of Immunological Receptors CD74 and CD44 in Association with the Macrophage Migration Inhibitory Factor (MIF) on Human Breast Cancer Derived Cells

  2016cites this paper
• Major Action of Endogenous Lysyl Oxidase in Clear Cell Renal Cell Carcinoma Progression and Collagen Stiffness Revealed by Primary Cell Cultures.

  2016cites this paper
• Neoplasms of the Kidney

  2016cites this paper
• General Overview of Renal Cell Carcinoma with the Evaluation of our cases

  2015cites this paper
• CD74 in Kidney Disease

  2015cites this paper
• Function of the CD74 receptor in B cell pro-survival signaling in the context of chronic lymphocytic leukemia

  2015cites this paper
• Multi Functional Diagnostic Exploitation of Human Galectin-3

  2015cites this paper
• The ROS1 Receptor Family

  2015cites this paper
• Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges

  2015cites this paper
• Computational Pathology: Challenges and Promises for Tissue Analysis

  2015cites this paper
• Human copper-dependent amine oxidases.

  2014cites this paper
• Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networks

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• The integral role of CD74 in antigen presentation, MIF signal transduction, and B cell survival and homeostasis.

  2014cites this paper
• High-density expression profiling of renal cell carcinomas from Saudi Arabia: a preliminary study

  2014cites this paper
• Recent advances of cluster of differentiation 74 in cancer

  2014cites this paper
• CD84 is a survival receptor for CLL cells

  2014cites this paper
• Ancillary Diagnostic Techniques in the Evaluation of Adult Epithelial Renal Neoplasms: Indications, Caveats, and Pitfalls

  2014cites this paper
• The application of immunohistochemical biomarkers in urologic surgical pathology.

  2014cites this paper
• Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma

  2014cites this paper
• Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma

  2014cites this paper
• RETRACTED CHAPTER: Molecular Testing in Adult Kidney Tumors

  2014cites this paper
• Automated Analysis of Tissue Micro-Array Images on the Example of Renal Cell Carcinoma

  2013cites this paper
• Arsenic immunotoxicity: a review

  2013cites this paper
• Potential role of genetic markers in the management of kidney cancer.

  2013cites this paper
• Kidney Cancer Genomics: Paving the Road to a New Paradigm of Personalized Medicine

  2013cites this paper
• High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients

  2013cites this paper
• Pancreatic metastases of renal clear cell carcinoma: a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas.

  2013cites this paper
• LMP step pattern detection based on real-time data

  2013cites this paper
• Targeted therapies and the treatment of non-clear cell renal cell carcinoma.

  2013cites this paper
• Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.

  2013cites this paper
• CD74 expression is increased in high‐grade, invasive urothelial carcinoma of the bladder

  2013cites this paper
• MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.

  2013cites this paper
• Milatuzumab–SN-38 Conjugates for the Treatment of CD74+ Cancers

  2013cites this paper
• and survival Cell surface CD74 initiates a signaling cascade leading to cell proliferation

  2013cites this paper
• Steroid Receptors in Renal Cell Carcinoma

  2012cites this paper
• Current Status of Biomarker Discovery in Human clear Cell Renal Cell Carcinoma

  2012cites this paper
• Hereditary syndromes of kidney cancer : chromosomal localisation , affected genes and pathways , and clinical features Syndrome Chromosome Gene / protein Potential pathway

  2012cites this paper
• Molecular Portrait of Clear Cell Renal Cell Carcinoma: An Integrative Analysis of Gene Expression and Genomic Copy Number Profiling

  2012cites this paper
• Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria

  2012cites this paper
• Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.

  2012cites this paper
• 5 Steroid Receptors in Renal Cell Carcinoma

  2012cites this paper
• Innovation thérapeutique dans la dysfonction endothéliale associée à l'hypertension artérielle pulmonaire

  2012cites this paper
• INSTRUCTIONS ON THE ANNOTATION OF PDF FILES

  2012cites this paper
• Tumor suppressive microRNA-138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma

  2012cites this paper
• Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

  2012cites this paper
• Renal tumor ablation: beyond limitations of biopsy and follow-up

  2012cites this paper
• CD10(+) and CK7/RON(−) Immunophenotype Distinguishes Renal Cell Carcinoma, Conventional Type With Eosinophilic Morphology From its Mimickers

  2012cites this paper
• Predictors of response to targeted therapy in renal cell carcinoma.

  2012cites this paper
• The contemporary role of renal mass biopsy in the management of small renal tumors

  2012cites this paper
• Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma.

  2012cites this paper
• Regulation of CLL survival by hypoxia‐inducible factor and its target genes

  2012cites this paper
• Renal Mass Biopsy

  2012cites this paper
• RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.

  2012influential citation
• The rationale for targeting the LOX family in cancer

  2012cites this paper
• Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome

  2012cites this paper
• Studies on Effects of Arsenic on Human Beta-Defensin-1

  2012influential citation
• Galectin-3 and Beclin1/Atg6 Genes In Human Cancers: Using cDNA Tissue Panel, qRT-PCR, and Logistic Regression Model to Identify Cancer Cell Biomarkers

  2011cites this paper
• Role of Immunohistochemistry in the Evaluation of Needle Core Biopsies in Adult Renal Cortical Tumors: An Ex Vivo Study

  2011cites this paper
• What can molecular pathology contribute to the management of renal cell carcinoma?

  2011cites this paper
• Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

  2011cites this paper